We investigated clinical and microbiological characteristics of 30 @entity1 with Brevundimonas @entity2259 treated at a tertiary care hospital in Taiwan during 2000-2010. All the 30 bacteria isolates were confirmed to the species level by 16S rRNA sequencing analysis. Minimum inhibitory concentrations (MICs) of 11 antimicrobial agents against these isolates were determined by the agar dilution method. Seventeen (57%) @entity1 had underlying @entity5 , 12 (40%) had undergone central catheter placement, and 13 (43%) had received chemotherapy within the previous three months. Eight (27%) @entity1 had community-acquired @entity2259 and the remaining 22 @entity1 (73%) had healthcare-associated @entity2259 . The overall 14-day and 30-day mortality rates were 13% and 17%, respectively. Among the 30 isolates, B. vesicularis constituted most commonly (n = 22, 63%), followed by B. nasdae (n = 5) and B. diminuta (n = 3). All isolates were susceptible to @entity3400 - @entity7120 and @entity4509 , while all were resistant to @entity2177 and @entity3273 . @entity9001 (MICs at which 90% of isolates are inhibited [MIC(90)] was 0.12 mg/L) and @entity19010 (MIC(90) of 1 mg/L) both possessed good in vitro activities. In conclusions, Brevundimonas should be considered a pathogen that can cause @entity2259 in immunocompromised hosts. @entity3400 - @entity7120 , @entity4509 , @entity19010 , and @entity9001 exhibit good in vitro activities against these @entity2177 - and @entity3273 -resistant Brevundimonas species.

XXXX caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000-2010.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity3273 :: ('MESH:D003091', 'Chemical') :: ['colistin'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignancy'] @entity19010 :: ('MESH:C099245', 'Chemical') :: ['doripenem'] @entity2177 :: ('MESH:D002939', 'Chemical') :: ['ciprofloxacin'] @entity7120 :: ('MESH:C043265', 'Chemical') :: ['tazobactam'] @entity4509 :: ('MESH:D000583', 'Chemical') :: ['amikacin'] @entity3400 :: ('MESH:D010878', 'Chemical') :: ['Piperacillin', 'piperacillin'] @entity2259 :: ('MESH:D016470', 'Disease') :: ['bacteremia'] @entity9001 :: ('MESH:C119092', 'Chemical') :: ['tigecycline', 'Tigecycline']
@entity2259 :: (MESH:D016470,Disease) :: ['Bacteremia']
